+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hemorrhoids Treatment Market Forecast to 2033- Product Image
Hemorrhoids Treatment Market Forecast to 2033- Product Image
New

Hemorrhoids Treatment Market Forecast to 2033

  • PDF Icon

    Report

  • 150 Pages
  • October 2025
  • Region: Global
  • Grand View Research
  • ID: 6189329
REQUEST CUSTOMIZATION
Description Jump to:
The global hemorrhoids treatment market size was estimated at USD 762.99 million in 2024 and is projected to reach USD 1.46 billion by 2033, growing at a CAGR of 7.5% from 2025 to 2033. The increasing prevalence of hemorrhoidal disorders is driving market growth, influenced by sedentary lifestyles, poor diets, rising obesity, and aging, which reduces tissue elasticity.

For instance, in December 2024, Journal of Disease and Global Health reported that 50% to 85% of the global population experienced hemorrhoids in their lifetime, with one-quarter of Africans over 50 affected. The study noted 3.3 million U.S. ambulatory-care visits, making hemorrhoids the fourth most common gastrointestinal disorder in outpatient settings. Mild to moderate cases were managed with fiber, hydration, and sitz baths, while severe cases used rubber band ligation, sclerotherapy, or infrared coagulation. Advanced cases required stapled hemorrhoidopexy or artery ligation, with postoperative care addressing pain, bleeding, and urinary retention. Greater awareness and diagnostic advances are driving timely interventions and treatment demand.

Technological innovations in hemorrhoid treatment methods are transforming patient care and supporting market expansion. Minimally invasive procedures, such as rubber band ligation, infrared coagulation, and laser therapy, offer faster recovery, reduced pain, and minimal complications, attracting more patients. Advanced topical formulations and oral medications improve symptom management and enhance patient adherence, while innovative combination therapies address multiple aspects of the disorder. For instance, in June 2024, Korea Biomedical Review reported that over 80% of the global population experiences hemorrhoids at some point, particularly individuals aged 45 to 65, with prevalence exceeding 50% in those over 50. The article emphasized early diagnosis, appropriate treatment strategies, and lifestyle modifications, including dietary changes and exercise, to manage and prevent complications. Clinics and hospitals increasingly implement these procedures to optimize outcomes and efficiency, reducing hospital stays and post-treatment follow-up requirements. Continuous improvements in treatment delivery and procedural techniques encourage wider adoption of these therapies, fostering growth across both developed and emerging markets globally.

Consumer demand for convenient, effective, and accessible hemorrhoid treatments is fueling market growth further. Over-the-counter ointments, suppositories, and oral supplements provide patients with practical options for self-care at home, while increasing awareness of lifestyle interventions encourages proactive symptom management. Marketing campaigns, educational initiatives, and digital platforms highlight the advantages and ease of use of modern treatments, enhancing patient engagement. Expanding distribution channels, including pharmacies, specialty clinics, and e-commerce platforms, ensure wider availability and accessibility. As patients increasingly prefer safe, minimally invasive, and home-based treatment solutions, manufacturers and healthcare providers continue to innovate, introducing new products and therapeutic options that meet evolving consumer expectations and needs.

Global Hemorrhoids Treatment Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global hemorrhoids treatment market report based on disease, drug class, distribution channel, and region:

Disease Outlook (Revenue, USD Million, 2021-2033)

  • Internal Hemorrhoids
  • External Hemorrhoids
  • Mixed Hemorrhoids

Drug Class Outlook (Revenue, USD Million, 2021-2033)

  • Corticosteroids
  • Local Anesthetics
  • Vasoconstrictors
  • Others

Distribution Channel Outlook (Revenue, USD Million, 2021-2033)

  • Online Pharmacy
  • Retail Pharmacy
  • Hospital Pharmacy

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Report Deliverables

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Disease
1.2.2. Drug Class
1.2.3. Distribution Channel
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Hemorrhoids Treatment Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
3.3.4. Pricing Analysis
Chapter 4. Hemorrhoids Treatment Market: Disease Business Analysis
4.1. Disease Market Share, 2024 & 2033
4.2. Disease Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Disease, 2021 to 2033 (USD Million)
4.4. Internal Hemorrhoids
4.4.1. Internal Hemorrhoids Market, 2021-2033 (USD Million)
4.5. External Hemorrhoids
4.5.1. External Hemorrhoids Market, 2021-2033 (USD Million)
4.6. Mixed Hemorrhoids
4.6.1. Mixed Hemorrhoids Market, 2021-2033 (USD Million)
Chapter 5. Hemorrhoids Treatment Market: Drug Class Business Analysis
5.1. Drug Class Market Share, 2024 & 2033
5.2. Drug Class Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Million)
5.4. Corticosteroids
5.4.1. Corticosteroids Market, 2021-2033 (USD Million)
5.5. Local Anesthetics
5.5.1. Local Anesthetics Market, 2021-2033 (USD Million)
5.6. Vasoconstrictors
5.6.1. Vasoconstrictors Market, 2021-2033 (USD Million)
5.7. Others
5.7.1. Others Market, 2021-2033 (USD Million)
Chapter 6. Hemorrhoids Treatment Market: Distribution Channel Business Analysis
6.1. Distribution Channel Market Share, 2024 & 2033
6.2. Distribution Channel Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
6.4. Online Pharmacy
6.4.1. Online Pharmacy Market, 2021-2033 (USD Million)
6.5. Retail Pharmacy
6.5.1. Retail Pharmacy Market, 2021-2033 (USD Million)
6.6. Hospital Pharmacy
6.6.1. Hospital Pharmacy Market, 2021-2033 (USD Million)
Chapter 7. Hemorrhoids Treatment Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2024 & 2033
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
7.4. North America
7.4.1. North America Hemorrhoids Treatment Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Target Disease Prevalence
7.4.2.3. Regulatory Framework
7.4.2.4. Reimbursement Framework
7.4.2.5. U.S. Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Regulatory Framework
7.4.3.4. Reimbursement Framework
7.4.3.5. U.S. Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.4. Mexico
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Regulatory Framework
7.4.4.4. Reimbursement Framework
7.4.4.5. Mexico Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5. Europe
7.5.1. Europe Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Target Disease Prevalence
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement Framework
7.5.2.5. Uk Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement Framework
7.5.3.5. Germany Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Regulatory Framework
7.5.4.4. Reimbursement Framework
7.5.4.5. France Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Regulatory Framework
7.5.5.4. Reimbursement Framework
7.5.5.5. Italy Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Target Disease Prevalence
7.5.6.3. Regulatory Framework
7.5.6.4. Reimbursement Framework
7.5.6.5. Spain Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.7. Denmark
7.5.7.1. Key Country Dynamics
7.5.7.2. Target Disease Prevalence
7.5.7.3. Regulatory Framework
7.5.7.4. Reimbursement Framework
7.5.7.5. Denmark Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.8. Sweden
7.5.8.1. Key Country Dynamics
7.5.8.2. Target Disease Prevalence
7.5.8.3. Regulatory Framework
7.5.8.4. Reimbursement Framework
7.5.8.5. Sweden Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Target Disease Prevalence
7.5.9.3. Regulatory Framework
7.5.9.4. Reimbursement Framework
7.5.9.5. Norway Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6. Asia-Pacific
7.6.1. Asia-Pacific Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Target Disease Prevalence
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement Framework
7.6.2.5. Japan Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement Framework
7.6.3.5. China Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement Framework
7.6.4.5. India Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.5. Australia
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement Framework
7.6.5.5. Australia Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.6. South Korea
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Regulatory Framework
7.6.6.4. Reimbursement Framework
7.6.6.5. South Korea Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Target Disease Prevalence
7.6.7.3. Regulatory Framework
7.6.7.4. Reimbursement Framework
7.6.7.5. Thailand Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7. Latin America
7.7.1. Latin America Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Target Disease Prevalence
7.7.2.3. Regulatory Framework
7.7.2.4. Reimbursement Framework
7.7.2.5. Japan Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Target Disease Prevalence
7.7.3.3. Regulatory Framework
7.7.3.4. Reimbursement Framework
7.7.3.5. China Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8. Middle East and Africa
7.8.1. Middle East and Africa Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Target Disease Prevalence
7.8.2.3. Regulatory Framework
7.8.2.4. Reimbursement Framework
7.8.2.5. South Africa Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Target Disease Prevalence
7.8.3.3. Regulatory Framework
7.8.3.4. Reimbursement Framework
7.8.3.5. Saudi Arabia Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Target Disease Prevalence
7.8.4.3. Regulatory Framework
7.8.4.4. Reimbursement Framework
7.8.4.5. UAE Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Target Disease Prevalence
7.8.5.3. Regulatory Framework
7.8.5.4. Reimbursement Framework
7.8.5.5. Kuwait Hemorrhoids Treatment Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. Lupin
8.5.1.1. Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. Cipla
8.5.2.1. Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. Amato Pharmaceutical Products, Ltd.
8.5.3.1. Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. Church & Dwight Co., Inc
8.5.4.1. Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. Haleon Group of Companies
8.5.5.1. Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. Sebela Pharmaceuticals
8.5.6.1. Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. Bayer AG
8.5.7.1. Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives
8.5.8. Sanofi
8.5.8.1. Overview
8.5.8.2. Financial Performance
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic Initiatives
8.5.9. Abbott
8.5.9.1. Overview
8.5.9.2. Financial Performance
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic Initiatives
8.5.10. Sun Pharmaceutical Industries, Inc
8.5.10.1. Overview
8.5.10.2. Financial Performance
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic Initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Global hemorrhoids treatment market, by region, 2021-2033 (USD Million)
Table 4. Global hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 5. Global hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 6. Global hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 7. North America hemorrhoids treatment market, by country, 2021-2033 (USD Million)
Table 8. North America hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 9. North America hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 10. North America hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 11. U.S. hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 12. U.S. hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 13. U.S. hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 14. Canada hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 15. Canada hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 16. Canada hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 17. Mexico hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 18. Mexico hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 19. Mexico hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 20. Europe hemorrhoids treatment market, by country, 2021-2033 (USD Million)
Table 21. Europe hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 22. Europe hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 23. Europe hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 24. UK hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 25. UK hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 26. UK hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 27. Germany hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 28. Germany hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 29. Germany hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 30. France hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 31. France hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 32. France hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 33. Italy hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 34. Italy hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 35. Italy hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 36. Spain hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 37. Spain hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 38. Spain hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 39. Norway hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 40. Norway hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 41. Norway hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 42. Denmark hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 43. Denmark hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 44. Denmark hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 45. Sweden hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 46. Sweden hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 47. Sweden hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 48. Asia-Pacific hemorrhoids treatment market, by country, 2021-2033 (USD Million)
Table 49. Asia-Pacific hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 50. Asia-Pacific hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 51. Asia-Pacific hemorrhoids treatment market, by distribution channel, 2021-2033 (USD
Table 52. Japan hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 53. Japan hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 54. Japan hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 55. China hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 56. China hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 57. China hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 58. India hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 59. India hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 60. India hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 61. Australia hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 62. Australia hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 63. Australia hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 64. South Korea hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 65. South Korea hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 66. South Korea hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 67. Thailand hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 68. Thailand hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 69. Thailand hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 70. Latin America hemorrhoids treatment market, by country, 2021-2033 (USD Million)
Table 71. Latin America hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 72. Latin America hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 73. Latin America hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 74. Brazil hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 75. Brazil hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 76. Brazil hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 77. Argentina hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 78. Argentina hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 79. Argentina hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 80. Middle East & Africa Hemorrhoids treatment market, by country, 2021-2033 (USD Million)
Table 81. Middle East & Africa hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 82. Middle East & Africa hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 83. Middle East & Africa hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 84. South Africa hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 85. South Africa hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 86. South Africa hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 87. Saudi Arabia hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 88. Saudi Arabia hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 89. Saudi Arabia hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 90. UAE hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 91. UAE hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 92. UAE hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
Table 93. Kuwait hemorrhoids treatment market, by disease, 2021-2033 (USD Million)
Table 94. Kuwait hemorrhoids treatment market, by drug class, 2021-2033 (USD Million)
Table 95. Kuwait hemorrhoids treatment market, by distribution channel, 2021-2033 (USD Million)
List of Figures
Figure 1 Hemorrhoids treatment market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 Market formulation & validation
Figure 8 Market snapshot
Figure 9 Therapeutic approach and disease outlook (USD Million)
Figure 10 Competitive landscape
Figure 11 Hemorrhoids treatment market dynamics
Figure 12 Hemorrhoids treatment market: Porter’s five forces analysis
Figure 13 Hemorrhoids treatment market: PESTLE analysis
Figure 14 Disease market, 2021-2033 (USD Million)
Figure 15 Internal Hemorrhoids market, 2021-2033 (USD Million)
Figure 16 External Hemorrhoids market, 2021-2033 (USD Million)
Figure 17 Mixed Hemorrhoids market, 2021-2033 (USD Million)
Figure 18 Drug Class market, 2021-2033 (USD Million)
Figure 19 Corticosteroids market, 2021-2033 (USD Million)
Figure 20 Local Anesthetics market, 2021-2033 (USD Million)
Figure 21 Vasoconstrictors market, 2021-2033 (USD Million)
Figure 22 Others market, 2021-2033 (USD Million)
Figure 23 Distribution channel market, 2021-2033 (USD Million)
Figure 24 Online pharmacy market, 2021-2033 (USD Million)
Figure 25 Retail pharmacy market, 2021-2033 (USD Million)
Figure 26 Hospital pharmacy market, 2021-2033 (USD Million)
Figure 27 Hemorrhoids treatment market revenue, by region
Figure 28 Regional marketplace: Key takeaways
Figure 29 North America hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 30 U.S. country dynamics
Figure 31 U.S. hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 32 Canada country dynamics
Figure 33 Canada hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 34 Mexico country dynamics
Figure 35 Mexico hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 36 Europe hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 37 UK country dynamics
Figure 38 UK hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 39 Germany country dynamics
Figure 40 Germany hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 41 France country dynamics
Figure 42 France hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 43 Italy country dynamics
Figure 44 Italy hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 45 Spain country dynamics
Figure 46 Spain hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 47 Norway country dynamics
Figure 48 Norway hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 49 Sweden country dynamics
Figure 50 Sweden hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 51 Denmark country dynamics
Figure 52 Denmark hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 53 Asia-Pacific hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 54 Japan country dynamics
Figure 55 Japan hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 56 China country dynamics
Figure 57 China hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 58 India country dynamics
Figure 59 India hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 60 Australia country dynamics
Figure 61 Australia hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 62 South Korea country dynamics
Figure 63 South Korea hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 64 Thailand country dynamics
Figure 65 Thailand hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 66 Latin America hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 67 Brazil country dynamics
Figure 68 Brazil hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 69 Argentina country dynamics
Figure 70 Argentina hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 71 MEA hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 72 South Africa country dynamics
Figure 73 South Africa hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 74 Saudi Arabia country dynamics
Figure 75 Saudi Arabia hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 76 UAE country dynamics
Figure 77 UAE hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 78 Kuwait country dynamics
Figure 79 Kuwait hemorrhoids treatment market, 2021-2033 (USD Million)
Figure 80 Company categorization
Figure 81 Company market position analysis
Figure 82 Strategic framework

Companies Mentioned

The companies profiled in this Hemorrhoids Treatment market report include:
  • Lupin
  • Cipla
  • Amato Pharmaceutical Products, Ltd.
  • Church & Dwight Co., Inc
  • Haleon Group of Companies
  • Sebela Pharmaceuticals
  • Bayer AG
  • Sanofi
  • Abbott
  • Sun Pharmaceutical Industries, Inc

Table Information

Report AttributeDetails
No. of Pages150
PublishedOctober 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 762.99 Million
Forecasted Market Value ( USD ) by 2033 $ 1460 Million
Compound Annual Growth Rate7.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Hemorrhoids - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Hemorrhoids - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Hemorrhoids Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Hemorrhoids Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 137 Pages
  • Global
From
Hemorrhoids - Pipeline Insight, 2025 - Product Image

Hemorrhoids - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Hemorrhoids Epidemiology Forecast 2025-2034 - Product Image

Hemorrhoids Epidemiology Forecast 2025-2034

  • Report
  • 150 Pages
  • Global
From
LAMEA Gastrointestinal Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Distribution Channel, By Route of Administration (Injectable and Oral & Others), By Application, By Drug Class, By Country and Growth Forecast, 2022 - 2028 - Product Image

LAMEA Gastrointestinal Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Distribution Channel, By Route of Administration (Injectable and Oral & Others), By Application, By Drug Class, By Country and Growth Forecast, 2022 - 2028

  • Report
  • 123 Pages
  • Africa, Middle East
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.